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Background: Right hepatectomy (RH) is the most common type of major hepatectomy and can be
achieved without portal triad clamping (PTC) in non-cirrhotic liver. The present study reviews our stan-
dardized policy of performing RH without systematic PTC.
Methods: One hundred and eighty-one consecutive RH were performed in non-cirrhotic patients, with
division of the right afferent and efferent blood vessels prior to transection, without systematically using
PTC. Prospectively collected data were analysed, focusing on the following endpoints: need for salvage
PTC, ischaemic time, blood loss and post-operative outcome.
Results: Extra-hepatic division of the right hepatic vessels was feasible in all patients, but was ineffec-
tive in 48 patients (26.5%) who required salvage PTC during transection. In those patients, the median
ischaemic time was 20 min. The median blood loss was 500 ml (50–3000). Six patients (3.3%) experi-
enced post-operative liver failure. Overall morbidity, severe morbidity and mortality were 42%, 12.1% and
1.6%, respectively, with peri-operative transfusion rate (16.6%) being the only factor associated with
morbidity.
Discussion: By performing RH with extra-hepatic vascular division prior to transection, PTC can be
safely avoided in the majority of patients.
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Introduction
During a hepatectomy, the need for bleeding control has general-
ized the use of continuous or intermittent total portal triad
clamping (PTC).1 However, PTC induces significant ischaemia/
reperfusion injuries on the remnant liver. These injuries constitute
a determinant factor in liver dysfunction,2 which is known to be a
main cause of post-operative mortality,3 particularly in major
hepatectomy. Moreover, it has been demonstrated that liver
metabolism and tissue oxygenation were markedly affected by
occlusion of the liver hilus.4,5 Finally, ischaemia/reperfusion inju-
ries have been associated with tumour growth in experimental
models.6,7 Whereas not demonstrated in human colorectal
metastases,8 a longer PTC time has been recently identified as a
predictor of shorter survival in patients undergoing liver resection
for hepatocellular carcinoma (HCC).9 Therefore, techniques of
selective vascular exclusion10 have been developed in order to
protect the remnant liver without significant increased blood loss.
Since the description of the first right hepatectomy under hemi-
occlusion of the afferent blood flow extra-hepatically by Lortat-
Jacob in 1952,11 the safety of liver resection under selective
vascular clamping has been demonstrated.12–15 Improvement of
this technique with concomitant control of the ipsilateral outflow
and preservation of the caval flow has further been reported.10,16
The technique has reached a high feasibility rate, as demonstrated
in the recent intention-to-treat study by Viganò et al.,17 in which
the requirement for salvage clamping was only 9.8%. Most of
these series, however, have included both cirrhotic and non-
cirrhotic patients or have involved various types of hepatectomy
(minor or major, anatomic or not), thus precluding any reliable
interpretation of the results with regard to the advantages of this
technique in each individual patient.
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A right hepatectomy is the most common major hepatectomy
performed by specialized and even non-specialized surgeons, in
patients without liver cirrhosis. As a result of the anatomy of the
right primary branch of the glissonean pedicle tree, which is
always located under the Glisson’s sheath18 and can be easily
encircled in most cases, a right hepatectomy may be especially
appropriate for extra-hepatic ligation and division of the ipsilat-
eral portal vein, hepatic artery and hepatic vein. Therefore, the
aim of the present study was to investigate, in a large cohort of
patients without chronic liver disease, the feasibility and the
results of a right hepatectomy initially performed without PTC,
using extra-hepatic vascular division prior to transection.
Methods
Patients
From January 2000 to December 2010, 281 consecutive right
hepatectomies were performed without systematic PTC for
benign or malignant diseases in the same institution. A right
hepatectomy was defined as resection of Couinaud’s segments 5 to
8 according to the Brisbane classification.19 After the exclusion of
patients with tumours involving the hepatocaval confluence (36
patients), resection of the middle hepatic vein (13 patients), con-
comitant resection of the caudate lobe (13 patients), concomitant
resection in the left liver (26 patients) or underlying chronic liver
disease, i.e. F3 or F4 fibrosis, according to the METAVIR classifi-
cation20 (31 patients), a total of 181 hepatectomies were analysed.
A hundred and fifteen patients had liver metastases of whom 62
(53.9%) have received a median of six cycles (range: 2–15) of
pre-operative chemotherapy. Baseline characteristics are summa-
rized in Table 1. Informed consent for the prospective collection
of clinical data was obtained from each patient. The conduct of
surgery and research was in accordance with the ethical guidelines
issued by the 2000 revision (Edinburgh) of the 1975 Declaration
of Helsinki.
Surgical procedure
There was no laparoscopic right hepatectomy. Open liver resec-
tions were performed using a right or bilateral subcostal incision,
except in seven patients in which a midline incision was selected
because of concomitant extrahepatic surgery or a previous
midline incision. The hepatic pedicle was always encircled in order
to perform salvage PTC whenever needed. An anterograde chole-
cystectomy was performed and a C-tube was inserted into the
cystic stump. Secondarily, the right branch of the hepatic artery
and the right branch of the portal vein were encircled and
clamped.At this time, an ischemic demarcation line could identify
both right and left livers and indicate the future parenchymal
section line. This might also eliminate any anatomical variation of
the right vascular pedicle distribution. Therefore, the right branch
of the portal vein could be safely stapled and divided using a linear
stapler (ATW35; Ethicon Endo-Surgery, Paris, France) and the
right branch of the hepatic artery was also ligated and divided. In
case of trifurcation of the portal trunk, the anterior and posterior
Table 1 Baseline characteristics in 181 patients undergoing a right
hepatectomy with systematic extra-hepatic vascular division prior to
transection
Patient characteristics n = 181
Age (years) 59 (17–82)
Male gender 107 (59.1%)
BMI (kg/m2) 24 (15–37)
ASA score
I 55 (30.4%)
II 87 (48.1%)
III 29 (16.0%)
Not specified 10 (5.5%)
Diabetes mellitus 29 (16.0%)
Indication for right hepatectomy
Liver metastases 115 (63.5%)
Hepatocellular carcinoma 32 (17.7%)
Cholangiocarcinoma 8 (4.4%)
Benign disease 26 (14.4%)
Previous cholecystectomy 8 (4.4%)
Re-hepatectomy 24 (13.3%)
Preoperative chemotherapya 62 (53.9%)
Pre-operative PVE 10 (5.5%)
Tumour size 8 cm 50 (27.6%)
Concomitant extra-hepatic surgery: 25 (13.8%)
Colectomy 5
Ileostomy closure 1
Nephrectomy 3
Adrenalectomy 8
Resection of the common bile duct + ‘Roux-en-Y’ 5
Left pancreatectomy 1
Parietal surgery 2
Liver fibrosisb
F0 150 (82.9%)
F1 15 (8.3%)
F2 16 (8.8%)
Liver steatosis
<30% 161 (89.0%)
30% 20 (11.0%)
aThe proportion of patients with pre-operative chemotherapy was calcu-
lated in the subgroup of patients with liver metastases. Only pre-
operative chemotherapy performed less than 12 weeks before surgery
was considered as having a potential impact on intra- and post-operative
outcome.63
bAccording to the METAVIR classification.20
Age and BMI are expressed as median (range).
BMI, body mass index; ASA, American Society of Anesthesiologists;
PVE, portal vein embolization.
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sectorial branches of the right portal vein were separately ligated
and divided. Some secondary portal branches for the right part of
segment I were eventually ligated. After mobilization of the right
ischaemic liver by section of the right triangular ligament, the
posterior aspect of segments VI and VII was separated from the
vena cava by ligating the caudate veins. After section of the hepa-
tocaval ligament, the right hepatic vein was stapled and divided
using a linear stapler (ATW35; Ethicon Endo-Surgery). Parenchy-
mal transection was systematically begun without PTC and per-
formed along the ischaemic demarcation line with an ultrasonic
dissector (Dissectron®; Satelec Medical, Integra™, Mérignac,
France). The right hepatic duct was found while separating
segment V from segment IV and ligated at the right border of the
hilar plate. To limit backflow from the suprahepatic veins, infused
fluids were restricted, as tolerated by the haemodynamic status,
until parenchyma transection was complete.21 The thresholds for
red blood cell (RBC) transfusion were a haemoglobin concentra-
tion of 7 g/dl for healthy patients 64 years of age or younger and
8 g/dl for patients 65 years of age or older or with pre-existing
cardiopulmonary disease. These criteria were consistent through-
out the study period.
During the parenchymal dissection, a salvage PTC was per-
formed in the following situations: (i) major bleeding from portal
or hepatocaval origin; (ii) cumulative blood loss exceeding 500 cc
from the beginning of the parenchymal transection; and (iii) dif-
ficulties in achieving correct control of the rough surface, because
of excessive oozing. This salvage PTC was continuous except when
the predictable ischaemic time was superior to 20 min. In this
case, an intermittent PTC was applied, with 15 min of ischaemic
time separated by reperfusion periods of 5 min.
Data collection and statistical analyses
Demographic and operative data, post-operative outcome and
pathological findings were prospectively collected. The three main
endpoints were intra-operative blood loss, requirement for a
salvage PTC and post-operative outcome. Intra-operative blood
loss was quantified by measuring suction bag volume and by
weighing the swabs. Major intra-operative blood loss was defined
as blood loss >1000 ml (90th percentile). The post-operative RBC
transfusion rate was calculated within the 7 post-operative days.
The mortality rate was defined using either the 30-day mortality
or the in-hospital mortality. Morbidity was classified according to
the Dindo and Clavien classification.22 Severe morbidity was
defined as grade III and more. Post-hepatectomy liver failure was
defined using the ‘50–50’ criteria.3 A biliary fistula was defined as
fluid in the abdominal drain with either the presence of biliary
salts or a bilirubin concentration at least three times greater than
in the serum on or after postoperative day 3, or as the need for
radiological intervention because of biliary collections or relap-
arotomy resulting from bile peritonitis (this definition was slightly
modified from Koch et al.23).
Continuous variables were expressed as median (range). Dif-
ferences between groups were explored using the Mann–Whitney
U-test. Categorical variables were reported as the number of
patients (prevalence in percentage) and differences between sub-
groups were compared using the two-sided Pearson’s c2 test or
Fisher’s exact test when appropriate. Pre- and intra-operative
variables that reached a univariate P-value < 0.1 were entered into
a logistic regression model, using a forward stepwise method, to
define which parameters were independently associated with
major intra-operative blood loss and morbidity. A P-value < 0.05
was considered statistically significant. The statistical analysis was
done using SPSS version 15.0 software (SPSS Inc., Chicago, IL,
USA).
Results
Intra-operative course
The median duration of surgery was 300 (175–630) min. The
right hepatic pedicle and the right hepatic vein were ligated before
the hepatectomy in all patients. In the 10 patients with previous
portal vein embolization, only one had pronounced inflammation
with difficulties in dissecting the right glissonean pedicle, which
was surrounded by an hypervascularized shift. In the eight
patients with a previous cholecystectomy, no technical difficulty
was noted during hilar dissection. There was no arterial or portal
injury in these 18 patients. Forty-eight patients (26.5%) required
a salvage PTC during transection. In these patients, the median
blood loss were significantly higher compared with patients
without PTC (600 vs. 400 ml; P < 0.0001) and the median clamp-
ing time was 20 min (range 5–96 min), including 18 patients
(37.5%) up to 15 min, 17 patients (35.4%) from 16 to 30 min, 8
patients (16.7%) from 31 to 60 min and 5 patients (10.4%) more
than 60 min. Intermittent PTC (n = 20; 41.7%), was performed
when total ischemic time exceeded 20 min, with a maximum of
96 min. As shown in Table 2, steatosis30% was the only signifi-
cant determinant factor for the requirement of a salvage PTC (P =
0.047). However, 5 of the 10 patients with pre-operative portal
vein embolization (PVE) also required a salvage PTC (P = 0.083).
The median intra-operative blood loss was 500 ml (50–3000).
Fourteen patients (7.7%) had an intra-operative RBC transfusion,
with 2 (range 1–4) RBC units per transfused patient. Significantly
increased intra-operative blood loss was observed in male patients
(500 vs. 375 ml; P < 0.001) or in patients with a body mass index
(BMI) of 30 kg/m2 or higher (650 vs. 450 ml; P = 0.026), hepato-
cellular carcinoma (600 vs. 442 ml; P = 0.014), tumour size over
8 cm (550 vs. 500 ml; P = 0.037) and steatosis 30% (625 vs.
450 ml; P = 0.013). (Table 3). Nineteen patients (10.5%) had
major intra-operative blood loss (>1000 ml). In univariate analy-
sis (Table 4), only male gender (84.2% vs. 56.2%; P = 0.019 was
significantly associated with major intra-operative blood loss.
There was a trend to significance for BMI (25 vs. 24 kg/m2; P =
0.052) and diabetes mellitus (42.1% vs. 21.6%; P = 0.082) to also
be associated with major intra-operative blood loss. Onmultivari-
ate analysis, only male gender (OR = 5.624; 95% CI: 1.239–25.520;
P = 0.025) was independently associated with major intra-
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operative blood loss. No patient experienced a clinical air embo-
lism or accidental devascularization of the left hemiliver.
Post-operative course
Three patients (1.6%) died post-operatively. One patient devel-
oped an acute thrombosis of a previous aorto-bifemoral bypass at
post-operative day one and required reoperation. He then devel-
oped fatal multiple organ failure syndrome at postoperative day 5.
The second patient had a massive cerebrovascular stroke and died
at postoperative day 5. The third patient developed a fatal myo-
cardial infarction 10 days after hepatectomy.
The median hospital stay was 9 days (range 5–55). The overall
morbidity rate was 42%, including 107 post-operative complica-
tions, detailed in Table 5. Severe morbidity occurred in 22 patients
(12.1%). Nineteen patients (10.5%) required post-operative RBC
transfusions, with 2 (range 2–7) RBC units per transfused patient.
These patients had a significant higher intra-operative blood loss
compared with patients without a post-operative transfusion (700
vs. 475 ml; P = 0.004). The overall peri-operative (intra- and post-
operative) RBC transfusion rate was 16.6%. The median tran-
saminases peaks on postoperative day 1 were 369 UI/l (range
78–3312) and 423 UI/l (34–3920) for aspartate amino-transferase
and alanine amino-transferase, respectively. Six patients (3.3%)
developed post-hepatectomy liver failure and this complication
was associated with one post-operative death. The prothrombin
time ratio and serum bilirubin level on postoperative day-5 were
75% (range 38–100) and 37 mmol/l (range 4–89), respectively. Ten
patients (5.5%) had transient renal insufficiency, of whom one
patient required dialysis. There was no digestive fistula in the 11
patients with concomitant gastrointestinal resection or ‘Roux-
en-Y’ procedure.
On univariate analysis, operative time (315 vs. 285 min; P =
0.022), intra-operative blood loss (500 vs. 400 ml; P = 0.041) and
the peri-operative transfusion rate (23.7% vs. 11.4%; P = 0.028)
were associated with post-operative morbidity (Table 6). In mul-
tivariate analysis, only peri-operative transfusion rate was an inde-
pendent determinant of morbidity (OR = 2.33; 95% CI: 1.043–
5.207; P = 0.039).
Discussion
For an anatomic major hepatectomy, an attractive strategy is to
use a partial hepatic devascularization technique to avoid
ischaemia of the remnant liver, splanchnic congestion (especially
in the case of concomitant gastrointestinal surgery) and haemo-
dynamic variations induced by continuous or intermittent PTC.24
Moreover, extra-hepatic division of the ipsilateral vessels before
transection induces selective ischaemia to the removed liver,
enables the surgeon to easily delineate the future cutting plan on
the liver surface and gives time for meticulous parenchymal
dissection and haemostasis, avoiding the haemorrhagic uncom-
fortable revascularization periods frequently associated with
intermittent PTC. Finally, it might decrease the risk of air embo-
lism25 owing to the ligature of the ipsilateral hepatic vein. For all
Table 2 Univariate analysis of determinant factors of salvage PTC during transection
Factors No PTC Salvage PTC P-value
(n = 133) (n = 48)
Age 61 (17–82) 63 (26–80) 0.887
Male gender 74 (55.6%) 33 (68.8%) 0.113
BMI (kg/m2) 24 (15–37) 24 (18–34) 0.992
ASA score III 22 (17.7%) 7 (14.9%) 0.658
Diabetes mellitus 35 (26.3%) 8 (16.7%) 0.178
Malignant disease 113 (85.0%) 42 (87.5%) 0.662
Liver metastases 84 (63.2%) 31 (64.6%) 0.865
Previous cholecystectomy 4 (3.0%) 4 (8.3%) 0.211
Re-hepatectomy 16 (12.0%) 8 (16.7%) 0.417
Pre-operative chemotherapya 47/84 (56.0%) 15/31 (48.4%) 0.470
Pre-operative PVE 5 (3.8%) 5 (10.4%) 0.083
Tumour size 8 cm 35 (26.3%) 15 (31.3%) 0.514
Concomitant surgery 21 (15.8%) 4 (8.3%) 0.207
F1-F2 liver fibrosisb 24 (18.0%) 7 (14.6%) 0.585
Steatosis 30% 11 (8.3%) 9 (18.8%) 0.047
aThe proportion of patients with pre-operative chemotherapy was calculated in the subgroup of patients with liver metastases. Only pre-operative
chemotherapy performed less than 12 weeks before surgery was considered as having a potential impact on the intra- and post-operative outcome.63
bAccording to the METAVIR classification.20
Age and BMI are expressed as median (range).
PTC, portal triad clamping; BMI, body mass index, ASA, American Society of Anesthesiologists; PVE, portal vein embolization.
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these reasons, we have adopted this technique since 2000 as a
systematic procedure for a right hepatectomy in non-cirrhotic
liver.
Several previous studies and three systematic reviews have com-
pared various clamping and non-clamping techniques in liver
resection.1,24–46 Apart from the superiority of intermittent PTC
over continuous PTC in patients with chronic liver disease,34 there
is no evidence to support one technique of vascular control over
another. In particular, one recent meta-analysis47 failed to demon-
strate any advantage of the hepatic vascular exclusion approaches.
However, most of the studies investigating the role of one-sided
selective clamping techniques (Table 7) have included both cir-
rhotic and non-cirrhotic patients or have involved various types
of hepatectomy (minor or major, anatomic or not). In addition,
occlusion of the ipsilateral outflowwas not routinely performed in
many of these studies. This may bring about various confounding
variables and preclude any reliable conclusion about the role of a
hemi-clamping approach in each individual patient. The present
study is the first report of a large cohort of patients without
underlying chronic liver disease undergoing a unique type of
major hepatectomy with the same procedure of vascular control
and parenchymal dissection (Table 7). A right hepatectomy was
selected because this largely used standard operative procedure is
reproducible with few anatomical variations. In addition, the
access to the right portal pedicle and to the right hepatic vein is
safe and makes extra-hepatic division of the right liver vessels an
easy procedure to perform.
Table 3 Values of intra-operative blood loss according to pre-
operative factors
Intra-operative
blood loss (mL)
P-value
Age 60 years 500 (50–2400) 0.873
>60 years 500 (50–3000)
Gender Male 500 (50–3000) <0.001
Female 375 (50–1350)
BMI (kg/m2) <30 450 (50–3000) 0.026
30 650 (50–2000)
ASA score I-II 500 (50–3000) 0.582
III 400 (200–2900)
Diabetes mellitus No 500 (50–3000) 0.572
Yes 450 (50–2900)
Malignant disease No 400 (50–1400) 0.386
Yes 500 (50–3000)
Hepatocellular carcinoma No 442 (50–3000) 0.014
Yes 600 (50–2000)
Liver metastases No 500 (50–2400) 0.205
Yes 500 (50–3000)
Previous cholecystectomy No 500 (50–3000) 0.860
Yes 400 (200–900)
Re hepatectomy No 500 (50–3000) 0.790
Yes 500 (100–2900)
Pre-operative
chemotherapya
No 500 (50–3000) 0.177
Yes 400 (50–2900)
Pre-operative PVE No 500 (50–3000) 0.586
Yes 525 (50–1700)
Tumour size 8 cm 500 (50–3000) 0.037
>8 cm 550 (50–2900)
Concomitant surgery No 500 (50–2900) 0.435
Yes 400 (150–3000)
Liver fibrosisb F0 450 (50–3000) 0.111
F1-F2 500 (100–1700)
Steatosis 30% No 450 (50–2900) 0.013
Yes 625 (200–3000)
aThe proportion of patients with pre-operative chemotherapy was calcu-
lated in the subgroup of patients with liver metastases. Only preoperative
chemotherapy performed less than 12 weeks before surgery was con-
sidered as having a potential impact on the intra- and post-operative
outcome.63
bAccording to the METAVIR classification.20
BMI, body mass index, ASA, American Society of Anaesthesiologists;
PVE, portal vein embolization.
Table 4 Univariate analysis of determinant factors of major intra-
operative blood loss (>1000 ml)
Factors 1000 ml >1000 ml P-value
(N = 162) (N = 19)
Age 61 (21–82) 63 (17–77) 0.704
Male gender 91 (56.2%) 16 (84.2%) 0.019
BMI (kg/m2) 24 (15–37) 25 (19–35) 0.052
ASA score III 24 (14.8%) 5 (26.3%) 0.195
Diabetes mellitus 35 (21.6%) 8 (42.1%) 0.082
Malignant disease 139 (85.8%) 17 (89.5%) 0.493
Hepatocellular
carcinoma
26 (16.0%) 5 (26.3%) 0.332
Liver metastases 104 (64.2%) 11 (57.9%) 0.541
Previous
cholecystectomy
8 (4.9%) 0 (0%) 0.404
Re hepatectomy 21 (13.0%) 3 (15.8%) 0.722
Pre-operative
chemotherapya
55/104 (52.9%) 7/11 (63.6%) 0.496
Pre-operative PVE 9 (5.6%) 1 (5.3%) 0.717
Tumour size 8 cm 30 (18.5%) 6 (31.6%) 0.217
Concomitant surgery 25 (15.4%) 2 (10.5%) 0.743
F1-F2 liver fibrosisb 27 (16.7%) 4 (21.1%) 0.747
Steatosis 30% 16 (9.9%) 4 (21.1%) 0.235
aThe proportion of patients with pre-operative chemotherapy was calcu-
lated in the subgroup of patients with liver metastases. Only pre-
operative chemotherapy performed less than 12 weeks before surgery
was considered as having a potential impact on the intra- and post-
operative outcome.63
bAccording to the METAVIR classification.20
Age and BMI are expressed as median (range).
BMI, body mass index, ASA, American Society of Anaesthesiologists;
PVE, portal vein embolization.
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Indeed, in the present series, vascular dissection and ligatures
could always be performed before parenchymal dissection and
this strategy was successful in nearly three-quarters of the patients
without the need for a salvage PTC. The rate of salvage PTC
requirement was slightly higher to the 21% rate, as previously
reported by Malassagne et al. in 43 patients with right and left
hepatectomies.10 This could be explained by a high proportion of
patients with pre-operative chemotherapy or steatosis. Indeed,
steatosis was the only determinant factor for salvage PTC require-
ment in the present series. The fragility of the steatotic paren-
chyma, with a high risk of damaging some tributaries to the
middle hepatic vein, may explain unexpected bleeding from the
left liver raw surface in spite of ischaemia of the right liver. Pre-
operative right PVE may be thought to be another cause of failure
of the extra-hepatic portal pedicle division, because of the diffi-
culty in dissecting the right portal vein. In the present series, the
division of the right portal vein was feasible in all 10 patients
receiving pre-operative PVE. Pronounced inflammation with dif-
ficulties in dissecting the right glissonean pedicle was described
in only one of these patients, but five required a salvage PTC,
although the PTC rate was not significantly higher compared with
patients without PVE (P = 0.083). In spite of the high rate of
salvage PTC, the total ischaemic time was brief, below 30 min
in the vast majority of patients, suggesting that, on an intent-
to-treat basis, this policy was effective for ischaemia sparing
of the remnant liver and may contribute to the low peak of
Table 5 List of 107 post-operative complications in 76 patientsa, according to the Dindo and Clavien classification of morbidity22
Complication I II IIIa IIIb Iva IVb V Total
Liver-related complications
Liver failureb 5 – – – – – 1 6
Biliary fistula 4 – 7 3 – – – 14
Ascites 11 3 – – – – – 14
Total liver-related complications 20 3 7 3 – – 1 34
Haemorrhage
Blood effusion or collection – 4 3 – – – – 7
Gastrointestinal bleeding – – 1 – – – – 1
Pulmonary complications
Pleural effusion 15 – 1 – – – – 16
Pneumonia – 4 – – – – – 4
Pulmonary embolism – 1 – – – – – 1
Acute respiratory distress syndrome – – – – 1 1 – 2
Non-pulmonary infections
Catheter infection 1 – – – – – – 1
Urinary infection – 1 – – – – – 1
Undetermined fever – 2 – – – – – 2
Subphrenical abcess – – 4 – – – – 4
Wound complications
Wound haematoma 9 – – – – – – 9
Evisceration – – – 1 – – – 1
Other
Acute renal failure – 9 – – 1 – – 10
Transient neurological confusion 6 – – – – – – 6
Peripheral venous thrombosis – 3 – – – – – 3
Thrombosis of a previous aortobifemoral bypass – – – 1 – – – 1
Transient cardiac failure – 1 – – – – – 1
Myocardial infarction – – – – – – 1 1
Cerebrovascular stroke – – – – – – 1 1
Multi-organ failure syndrome – – – – – – 1 1
Total 51 28 16 5 2 1 4 107
a23 patients had more than one complication.
bLiver failure was defined using the ‘50–50’ criteria.3
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transaminases and the high rate of post-operative liver recovery
(97% after post-operative day 5).
The median operative time was 5 h, which is similar to opera-
tive times reported in the literature for a major hepatectomy
without PTC (221–318 min),10,36,45 but higher compared with
some series of major hepatectomy under PTC (180–220).30,45,48
Thus, it is likely that the unclamping technique is associated with
an increase in operative time, as suggested by a recent retrospec-
tive study.45 In terms of intra-operative blood loss and transfusion
rate, the present series compares favourably with previous
reported series of a major hepatectomy in non-cirrhotic
patients,28,30,40,48–51 in which the median blood loss varied from 250
to 989 ml. A recent Japanese study reported a 14% rate of blood
loss exceeding 1500 ml in patients without underlying liver dis-
ease.52 This rate was only 5.5% in the present series. The peri-
operative RBC transfusion rate (17%) was also similar to previous
series of major hepatectomy in non-cirrhotic patients, in which it
varies largely from 6% to 63%, as it may depend on centres trans-
fusion policies.10,26,27,30,48,49,51,53,54 In addition, as expected from the
partial outflow control enabled by the technique,25 the incidence
of clinical air embolism was nil in the present series, although
damage to the middle hepatic vein is still possible.
Two classic hazards have been raised against the use of extra-
hepatic division of the vessels: there is a risk of hepatic vein or
vena cava injury during the extrahepatic dissection of the hepatic
veins and a risk of devitalizing the remnant liver by an erroneous
ligation of a glissonean pedicle in the hilum, which is increased by
the frequency of anatomical abnormalities. Thus, Bismuth advo-
cated in 1982 not to divide the inflow vessels prior to transection
and reported a technique combining the advantages of the Lortat-
Jacob and the Ton That Thung approaches:12 the ipsilateral pedicle
was dissected and clamped but not divided until the portal ele-
ments were identified by a superior approach inside the paren-
chyma. Also, the right flank of the retrohepatic inferior vena cava
was freed without systematically attempting to dissect the right
hepatic vein. However, thanks to the improvement of the knowl-
edge of the retrohepatic and hepatocaval confluence anatomy,
which is especially associated with the progresses in liver trans-
Table 6 Univariate analysis of overall morbiditya
Patients without morbidity Patients with morbidity P-value
(N = 105) (N = 76)
Age 60 (17–82) 64 (21–82) 0.147
Male gender 59 (56.2%) 48 (63.2%) 0.347
BMI (kg/m2) 24 (15–36) 24 (16–37) 0.632
ASA score III 14 (13.3%) 15 (19.7%) 0.250
Diabetes mellitus 25 (23.8%) 18 (23.7%) 0.984
Malignant disease 91 (86.7%) 65 (85.5%) 0.826
Liver metastases 70 (66.7%) 45 (59.2%) 0.421
Previous cholecystectomy 4 (3.8%) 4 (5.3%) 0.722
Re-hepatectomy 12 (11.4%) 12 (15.8%) 0.393
Preoperative chemotherapyb 40/70 (57.1%) 22/45 (48.9%) 0.386
Preoperative PVE 5 (4.8%) 5 (6.6%) 0.744
Tumour size 8 cm 17 (16.2%) 13 (17.1%) 0.893
F1-F2 liver fibrosisc 16 (15.2%) 15 (19.7%) 0.428
Steatosis 30% 11 (10.5%) 9 (11.8%) 0.772
Operative time (min) 285 (175–530) 315 (180–630) 0.013
Concomitant surgery 16 (15.2%) 11 (14.5%) 0.887
PTC requirement 24 (22.9%) 24 (31.6%) 0.190
Ischaemia time (min) 0 (0–91) 0 (0–96) 0.198
Blood loss (mL) 450 (50–2900) 500 (50–3000) 0.047
Peri-operative transfusion 12 (11.4%) 18 (23.7%) 0.029
Intra-operative transfusion 5 (4.8%) 10 (13.2%) 0.052
Post-operative transfusion 9 (8.6%) 10 (13.2%) 0.320
aOverall morbidity was defined as Dindo and Clavien22 grade I or more.
bThe proportion of patients with pre-operative chemotherapy was calculated in the subgroup of patients with liver metastases. Only pre-operative
chemotherapy performed less than 12 weeks before surgery was considered as having a potential impact on the intra- and post-operative outcome.63
cAccording to the METAVIR classification.20
Age, BMI operative time and blood loss are expressed as median (range).
BMI, body mass index; ASA, American Society of Anesthesiologists; PVE, portal vein embolization; PTC, portal triad clamping.
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plant surgery, and the use of low central venous pressure during
liver surgery, accidental injuries of hepatic veins or vena cava
during the retrohepatic dissection step have become rare and
mostly as a result of huge liver masses or a previous hepatectomy.
Moreover, in contrast to a more challenging liver resection such as
a mesohepatectomy55 or a hepatectomy in cirrhotic livers, the
encirclement of the right hepatic vein during a right hepatectomy
in non-cirrhotic livers is a safe and easy step in the majority of
patients. Regarding the risk of right glissonean pedicle division
prior to parenchymal dissection, there was no accidental devascu-
larization of the left remnant hemi-liver in the present series. In
fact, anatomical variations of the extrahepatic portal vein are
infrequent and mostly located to the left side. One of them is the
anterior right portal vein originating from the left portal vein,
which is observed in 2% of the subjects56 and may explain the risk
of right remnant hemi-liver devascularization after left hepatec-
tomy. In contrast, the symmetrical variation has never been
described and extra-hepatic division of the portal vein before
transection in a right hepatectomy may not be as risky as in a left
hepatectomy. In addition, checking the ischaemic liver territory by
clamping the right portal pedicle prior to division is undoubtedly
a key step in performing this technique safely. Infrahepatic vena
cava clamping has been another means to reduce bleeding during
parenchymal dissection. By lowering the central venous pressure,
this manoeuver decreases the venous backflow that occurs along
the liver cut surface in spite of portal triad clamping.57 Two ran-
domized studies assessing the role of concomitant infrahepatic
vena cava clamping are available in the literature with conflicting
results. The first one58 included mostly patients undergoing minor
hepatectomies and failed to show any reduction of bleeding in the
clamping group. The second trial59 showed a significant decrease
in intra-operative blood loss but without any impact on morbid-
ity or mortality. Half clamping of the infra-hepatic vena cava with
a tourniquet, in association with portal triad clamping, has also
Table 7 Main series including major hepatectomies performed without portal triad clamping in the past 15 years
Authors Year Type of
study
Number of
patients
(MH / RH)
Chronic
liver
disease
(%)
Vascular
controla
Intra-
operative
blood loss
(ml)
Transfusion
rate or
blood unit
per patient
Overall
morbidity
Severe
morbidity
Mortality
Malassagne
et al.10
1998 Cohort 43 / 36 14% r-SHVE
or l-SHVE
Ns 35% 18.6% 11.6% 2%
Descottes
et al.49
2003 Cohort 87 / 73 0% r-Inflow 980 52% 26% NS 4.6%
Scatton
et al.51
2004 Cohort 50 / 26 12% None
or r-Inflow
or l-Inflow
250 26% 16%
(surgical)
20%
(medical)
6% 0%
Moug
et al.16
2007 Cohort 59 / 30 3% r-SHVE
or l-SHVE
450 0% 20% 1% 0%
Ercolani
et al.31
2008 Cohort 393 / ns 27% PTC
or r-Inflow
or l-Inflow
or THVE
Ns 0.59 unit 23.4% NS 2.1%
Fu et al.42 2011 Ran-domized
control trial
108 / 52 60% r-Inflow
or l-Inflow
vs. MPV
vs. PTC
354 6.7% 20% NS 0%
Li et al.50 2011 Cohort 60 / 60 0% r-Inflow 595 0.42 unit 35% 8.4% 0%
Wong
et al.45
2011 Cohort 124 / 124 31% r-Inflow
(or none)
vs. PTC
450 10.3% 22.4% NS 1.7%
Viganò
et al.17
2011 Cohort 171 / 92 8% r-SHVE
or l-SHVE
450 14.3% 38.3% NS 1.2%
Present
series
Cohort 181 / 181 0% r-SHVE 500 16.6%
0.45 unit
42% 12% 1.6%
Studies that focused exclusively on a hepatectomy in patients with cirrhosis have been excluded.
When data were available for distinct groups, only those from the group with major or a right hepatectomy without portal triad clamping have been
presented.
aTechniques of vascular control: PTC, total portal triad clamping (continuous or intermittent). r-Inflow/l-Inflow, clamping/division of the right/left portal
vein and hepatic artery. r-SHVE/l-SHVE, clamping/division of the right/left portal vein and hepatic artery + clamping/division of the ipsi-lateral hepatic
vein (selective hepatic vascular exclusion/devascularization). THVE, Total hepatic vascular exclusion without preservation of the caval flow. MPV,
Clamping of the main portal vein.
MH, major hepatectomy; RH, right hepatectomy; NS, not specified.
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been reported to be associated with a lower central venous pres-
sure and a significant decrease in intra-operative blood loss.60
Although never performed in the present series, this manoeuver
may be associated with hemivascular control of the right liver in a
right hepatectomy, as it might decrease supra-hepatic backflow
even in the absence of portal triad clamping and, therefore, might
decrease the probability to require salvage portal triad clamping
during transection. It might also be useful in case of vena cava
injury during the hepatocaval dissection prior to transection.
Post-operative mortality and morbidity rates (1.6% and 42%
respectively) were comparable to previous series of major hepa-
tectomy in non-cirrhotic patients.10,26,27,30,40,48,49,51,53,54 The prospec-
tive collection of post-operative data and the strict accordance to
the five-tier grading of the Dindo and Clavien classification,22 may
explain the high rate of overall morbidity, whereas less than 20%
of patients experienced morbidity of grade II and more. More-
over, every single complication and its associated grade of severity
was reported in detail (Table 4) in order to present a comprehen-
sive analysis of the outcome after a right hepatectomy with the
unclamping policy. The rate of biliary fistula was 7.7%, but only
5.5% of patients required percutaneous or surgical management.
By reducing the time constraint with regard to ischaemic insult to
the remnant liver, the unclamping technique may give more time
for the surgeon to perform meticulous ligations of the biliary
stumps. Another advantage of the unclamping technique is the
avoidance of haemodynamic changes and splanchnic congestion
associated with total interruption of the liver inflow, and the
hypothesis that it may reduce the risk of post-operative renal
failure. Interestingly, none of the 11 patients with a concomitant
gastrointestinal resection or ‘Roux-en-Y’ procedure experienced a
digestive fistula and only one patient required post-operative
dialysis. Classic factors of post-operative morbidity were found,
i.e. operative time, intra-operative blood loss and peri-operative
transfusions, the latter being independently associated with mor-
bidity as already demonstrated.61
The main limitation of the present study is represented by its
retrospective design and the lack of a control group. This pre-
cludes drawing any firm conclusion about indications, timing and
effectiveness of a salvage PTC during transection. In addition, any
comparison of outcome between patients with and without PTC
was omitted, as the two groups were obviously not comparable.
We also failed to determine any pre-operative factor associated
with major intra-operative blood loss, which would give an indi-
cation to perform an initial PTC prior to transection, except male
gender. Although we did not find any confounding variables, such
as hepatocellular carcinoma, this association must be carefully
interpreted. It seems difficult to conclude that portal triad clamp-
ing should initially have been performed in men and that extra-
hepatic vascular control should only be indicated in women. BMI
and diabetes mellitus were other factors that tend to be associated
with major intra-operative blood loss, although not significantly.
As a result of the small size of the group of patients with major
intra-operative blood loss, it is likely that this study lacked power
to demonstrate a significant association with high BMI and dia-
betes mellitus. We might then suggest that performing initial
portal triad clamping prior to transection would have been better
in this subgroup of patients.
Overall, given the size and the homogeneity of the cohort, the
present study brings evidence to validate the policy of a selective
use of PTC during transection rather than a systematic upfront
PTC in right hepatectomy. In addition, it provides comprehensive
data on the expected results of a right hepatectomy performed
with this procedure of vascular control. Although this technique
was performed by a single team, there are some arguments to
think that wide applicability of the reported results is likely. All
hepatectomies of the present series were performed over a 10-year
period by several faculty surgeons or graduating chief residents.
We report herein the overall results of the technique, regardless of
the presumable heterogeneity in the surgeons’ technical skills. The
technique of extra-vascular control of hepatic pedicles prior to
transection has become a standard that several surgeons perform-
ing liver resection have adopted worldwide and whose reproduc-
ibility has already been demonstrated.14,15,17 As a result of
favourable anatomical conditions, vascular control of the right
glissonean pedicle and right hepatic vein may be performed easily
in a high reproducible manner in most cases. In addition, the
ischaemic line drawn on the liver surface after division of the right
pedicle enables the surgeon to easily delineate the future cutting
plan. Therefore, this technique of a right hepatectomy in non-
cirrhotic livers is considered in our team as one of the essential
surgical procedures for graduating chief residents to achieve com-
petence in hepato-pancreato-biliary surgery.
There are, however, some tricks and pitfalls we may discuss
from our technical experience with this technique, and especially
from what we learned during the study period:
Safe extrahepatic division of the right portal vein
As discussed above, the primary branches of the portal vein are
always extrahepatic, i.e. located below the reflection line of Glis-
son’s capsula. Two anatomical conditions may however induce
technical difficulties in dissecting the right portal vein. First, the
length of the common trunk may be very short before the origin
of the sectional branches. At most, the surgeon may deal with a
portal vein trifurcation. In this case, the posterior branch should
first be ligated and divided, then the encirclement of the anterior
branch would be easier. Second, the shape of the parenchyma
surrounding the right part of the hilum may be very different
in each subject. In some cases, the right portal vein, although
remaining extracapsular, enters into a deep valley made by the
convexity of segments IV,V,VI and I on each side of the hilum. In
this case, safe access to the right portal vein may be more difficult
and a vascular ligation should be preferred than vascular stapling.
In all cases, in order to lengthen the right portal vein, the right
branch of the hepatic artery should first be ligated and divided
and all the tributaries to segment 1, arising from the posterior
aspect of the right portal vein, should also be ligated and divided.
696 HPB
HPB 2012, 14, 688–699 © 2012 International Hepato-Pancreato-Biliary Association
When the vascular stapler can not be used, the right branch of the
portal vein can be ligated by a silk ligature and divided. This
ligature should be placed without pulling the vein out to avoid any
portal vein stenosis and, as it may slip from the venous stump like
a champagne cork, it can be secured to the venous wall, using a
polypropylene stitch. Finally, the origin of the left portal vein
should be carefully identified by extensively dissecting the anterior
aspect of the main portal trunk.
Division of the right glissonean pedicle should come
before hepatocaval dissection
This has many advantages. After division of the right glissonean
pedicle, every clamp can be removed from the portal triad. Thus,
the liver rotation to the left around the vena cava may be easier.
Additionally, as the right liver has been devascularized, its mobi-
lization becomes easier and any haemorrhage on the capsula or on
the hepatic stump of the accessory hepatic veins is minimal and
can be easily controlled.
Optimizing parenchymal dissection
The so-called hanging manoeuver has been reported as part of the
anterior approach technique.62 However, it can easily be used after
hepatocaval dissection and right hepatic vein transection to facili-
tate the exposure of the deeper part of the parenchyma, anterior to
the vena cava. During parenchymal dissection, bleeding may
sometimes be because of fluid overload. Adequate communica-
tion between surgeons and anaesthesiologists is of upmost impor-
tance, especially during right liver mobilization.
In conclusion, in spite of an increasing challenging patient
population with pre-operative chemotherapy or liver steatosis,
systematic extra-hepatic vascular division prior to transection and
selective use of PTC during transection can be safely performed in
a right hepatectomy. This policy will avoid any ischaemic insult to
the remnant liver in the majority of patients while minimizing the
cumulative ischaemic time in the remaining patients.
Conflicts of interest
None declared.
References
1. Man K, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. (1997) Prospective
evaluation of Pringle maneuver in hepatectomy for liver tumors by a
randomized study. Ann Surg 226:704–711. discussion 711–703.
2. Vollmar B, Glasz J, Leiderer R, Post S, Menger MD. (1994) Hepatic
microcirculatory perfusion failure is a determinant of liver dysfunction in
warm ischemia-reperfusion. Am J Pathol 145:1421–1431.
3. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D et al.
(2005) The ‘50–50 criteria’ on postoperative day 5: an accurate predictor
of liver failure and death after hepatectomy. Ann Surg 242:824–828.
discussion 828–829.
4. Brooks AJ, Hammond JS, Girling K, Beckingham IJ. (2007) The effect of
hepatic vascular inflow occlusion on liver tissue pH, carbon dioxide, and
oxygen partial pressures: defining the optimal clamp/release regime for
intermittent portal clamping. J Surg Res 141:247–251.
5. Pietsch UC, Herrmann ML, Uhlmann D, Busch T, Hokema F, Kaisers UX
et al. (2010) Blood lactate and pyruvate levels in the perioperative period
of liver resection with Pringle maneuver. Clin Hemorheol Microcirc
44:269–281.
6. Ozawa S, Akimoto N, Tawara H, Yamada M, Sato T, Tashiro J et al. (2011)
Pringle maneuver induces hepatic metastasis by stimulating the tumor
vasculature. Hepatogastroenterology 58:122–126.
7. van der Bilt JD, Kranenburg O, Nijkamp MW, Smakman N, Veenendaal
LM, Te Velde EA et al. (2005) Ischemia/reperfusion accelerates the out-
growth of hepatic micrometastases in a highly standardized murine
model. Hepatology 42:165–175.
8. Giuliante F, Ardito F, Pulitano C, Vellone M, Giovannini I, Aldrighetti L et al.
(2010) Does hepatic pedicle clamping affect disease-free survival
following liver resection for colorectal metastases? Ann Surg 252:1020–
1026.
9. Ishizuka M, Kubota K, Kita J, Shimoda M, Kato M, Sawada T. (2011)
Duration of hepatic vascular inflow clamping and survival after liver resec-
tion for hepatocellular carcinoma. Br J Surg 98:1284–1290.
10. Malassagne B, Cherqui D, Alon R, Brunetti F, Humeres R, Fagniez PL.
(1998) Safety of selective vascular clamping for major hepatectomies.
J Am Coll Surg 187:482–486.
11. Lortat-Jacob JL, Robert HG. (1952) [Well defined technic for right hepa-
tectomy]. Presse Med 60:549–551.
12. Bismuth H. (1982) Surgical anatomy and anatomical surgery of the liver.
World J Surg 6:3–9.
13. Gotoh M, Monden M, Sakon M, Kanai T, Umeshita K, Nagano H et al.
(1994) Hilar lobar vascular occlusion for hepatic resection. J Am Coll Surg
178:6–10.
14. Makuuchi M, Mori T, Gunven P, Yamazaki S, Hasegawa H. (1987) Safety
of hemihepatic vascular occlusion during resection of the liver. Surg
Gynecol Obstet 164:155–158.
15. Yanaga K, Matsumata T, Nishizaki T, Shimada M, Sugimachi K. (1993)
Alternate hemihepatic vascular control technique for hepatic resection.
Am J Surg 165:365–366.
16. Moug SJ, Smith D, Leen E, Angerson WJ, Horgan PG. (2007) Selective
continuous vascular occlusion and perioperative fluid restriction in partial
hepatectomy. Outcomes in 101 consecutive patients. Eur J Surg Oncol
33:1036–1041.
17. Viganò L, Jaffary SA, Ferrero A, Russolillo N, Langella S, Capussotti L.
(2011) Liver resection without pedicle clamping: feasibility and need for
‘salvage clamping’. Looking for the right clamping policy. analysis of 512
consecutive resections. J Gastrointest Surg 15:1820–1828.
18. Takasaki K. (2007) Glissonean Pedicle Transection Method for Hepatic
Resection. Tokyo: Springer, p. 171.
19. Belghiti J, Clavien PA, Gadzijev E, Garden JO, Lau WY, Makuuchi M
et al. (2000) The Brisbane 2000 terminology of liver anatomy and
resections (Terminology committee of the IHPBA). HBP 2:333–
339.
20. The French METAVIR Cooperative Study Group. (1994) Intraobserver and
interobserver variations in liver biopsy interpretation in patients with
chronic hepatitis C. Hepatology 20:15–20.
21. Lentschener C, Ozier Y. (2002) Anaesthesia for elective liver
resection: some points should be revisited. Eur J Anaesthesiol 19:780–
788.
22. Dindo D, Demartines N, Clavien PA. (2004) Classification of surgical
complications: a new proposal with evaluation in a cohort of 6336
patients and results of a survey. Ann Surg 240:205–213.
HPB 697
HPB 2012, 14, 688–699 © 2012 International Hepato-Pancreato-Biliary Association
23. Koch M, Garden OJ, Padbury R, Rahbari NN, Adam R, Capussotti L et al.
(2011) Bile leakage after hepatobiliary and pancreatic surgery: a definition
and grading of severity by the International Study Group of Liver Surgery.
Surgery 149:680–688.
24. Chouker A, Schachtner T, Schauer R, Dugas M, Lohe F, Martignoni A
et al. (2004) Effects of Pringle manoeuvre and ischaemic preconditioning
on haemodynamic stability in patients undergoing elective hepatectomy:
a randomized trial. Br J Anaesth 93:204–211.
25. Zhou W, Li A, Pan Z, Fu S, Yang Y, Tang L et al. (2008) Selective hepatic
vascular exclusion and Pringle maneuver: a comparative study in liver
resection. Eur J Surg Oncol 34:49–54.
26. Azoulay D, Lucidi V, Andreani P, Maggi U, Sebagh M, Ichai P et al. (2006)
Ischemic preconditioning for major liver resection under vascular exclu-
sion of the liver preserving the caval flow: a randomized prospective
study. J Am Coll Surg 202:203–211.
27. Belghiti J, Noun R, Malafosse R, Jagot P, Sauvanet A, Pierangeli F et al.
(1999) Continuous versus intermittent portal triad clamping for liver
resection: a controlled study. Ann Surg 229:369–375.
28. Belghiti J, Noun R, Zante E, Ballet T, Sauvanet A. (1996) Portal triad
clamping or hepatic vascular exclusion for major liver resection. A con-
trolled study. Ann Surg 224:155–161.
29. Capussotti L, Muratore A, Ferrero A, Massucco P, Ribero D, Polastri R.
(2006) Randomized clinical trial of liver resection with and without hepatic
pedicle clamping. Br J Surg 93:685–689.
30. Clavien PA, Selzner M, Rudiger HA, Graf R, Kadry Z, Rousson V et al.
(2003) A prospective randomized study in 100 consecutive patients
undergoing major liver resection with versus without ischemic precondi-
tioning. Ann Surg 238:843–850. discussion 851–842.
31. Ercolani G, Ravaioli M, Grazi GL, Cescon M, Del Gaudio M, Vetrone G
et al. (2008) Use of vascular clamping in hepatic surgery: lessons learned
from 1260 liver resections. Arch Surg 143:380–387. discussion 388.
32. Esaki M, Sano T, Shimada K, Sakamoto Y, Takahashi Y, Wakai K et al.
(2006) Randomized clinical trial of hepatectomy using intermittent pedicle
occlusion with ischaemic intervals of 15 versus 30 minutes. Br J Surg
93:944–951.
33. Figueras J, Llado L, Ruiz D, Ramos E, Busquets J, Rafecas A et al. (2005)
Complete versus selective portal triad clamping for minor liver resections:
a prospective randomized trial. Ann Surg 241:582–590.
34. Gurusamy KS, Kumar Y, Ramamoorthy R, Sharma D, Davidson BR.
(2009) Vascular occlusion for elective liver resections. Cochrane Data-
base Syst Rev (1):CD007530.
35. Lau WY, Lai EC, Lau SH. (2010) Methods of vascular control technique
during liver resection: a comprehensive review. Hepatobiliary Pancreat
Dis Int 9:473–481.
36. Lee KF, Wong J, Ng W, Cheung YS, Lai P. (2009) Feasibility of liver
resection without the use of the routine Pringle manoeuver: an analysis of
248 consecutive cases. HPB 11:332–338.
37. Li SQ, Liang LJ, Huang JF, Li Z. (2004) Ischemic preconditioning protects
liver from hepatectomy under hepatic inflow occlusion for hepatocellular
carcinoma patients with cirrhosis. World J Gastroenterol 10:2580–
2584.
38. Man K, Lo CM, Liu CL, Zhang ZW, Lee TK, Ng IO et al. (2003) Effects of
the intermittent Pringle manoeuvre on hepatic gene expression and ultra-
structure in a randomized clinical study. Br J Surg 90:183–189.
39. Nuzzo G, Giuliante F, Giovannini I, Vellone M, De Cosmo G, Capelli G.
(2001) Liver resections with or without pedicle clamping. Am J Surg
181:238–246.
40. Petrowsky H, McCormack L, Trujillo M, Selzner M, Jochum W, Clavien
PA. (2006) A prospective, randomized, controlled trial comparing inter-
mittent portal triad clamping versus ischemic preconditioning with con-
tinuous clamping for major liver resection. Ann Surg 244:921–928.
discussion 928–930.
41. Rahbari NN, Wente MN, Schemmer P, Diener MK, Hoffmann K, Motschall
E et al. (2008) Systematic review and meta-analysis of the effect of portal
triad clamping on outcome after hepatic resection. Br J Surg 95:424–
432.
42. Si-Yuan FU, Yee LW, Guang-Gang L, Qing-He T, Ai-Jun LI, Ze-Ya PA et al.
(2011) A prospective randomized controlled trial to compare Pringle
maneuver, hemihepatic vascular inflow occlusion, and main portal vein
inflow occlusion in partial hepatectomy. Am J Surg 201:62–69.
43. Smyrniotis V, Theodoraki K, Arkadopoulos N, Fragulidis G, Condi-Pafiti
A, Plemenou-Fragou M et al. (2006) Ischemic preconditioning versus
intermittent vascular occlusion in liver resections performed under selec-
tive vascular exclusion: a prospective randomized study. Am J Surg
192:669–674.
44. Sugiyama Y, Ishizaki Y, Imamura H, Sugo H, Yoshimoto J, Kawasaki S.
(2010) Effects of intermittent Pringle's manoeuvre on cirrhotic compared
with normal liver. Br J Surg 97:1062–1069.
45. Wong JS, Lee KF, Cheung YS, Chong CN, Wong J, Lai PB. (2011)
Modification of right hepatectomy results in improvement outcome: a
retrospective comparative study. HPB 13:431–437.
46. Wu CC, Yeh DC, Ho WM, Yu CL, Cheng SB, Liu TJ et al. (2002) Occlusion
of hepatic blood inflow for complex central liver resections in cirrhotic
patients: a randomized comparison of hemihepatic and total hepatic
occlusion techniques. Arch Surg 137:1369–1376.
47. Rahbari NN, Koch M, Mehrabi A, Weidmann K, Motschall E, Kahlert C
et al. (2009) Portal triad clamping versus vascular exclusion for vascular
control during hepatic resection: a systematic review and meta-analysis.
J Gastrointest Surg 13:558–568.
48. Abu Hilal M, Di Fabio F, Teng MJ, Lykoudis P, Primrose JN, Pearce NW.
(2011) Single-centre comparative study of laparoscopic versus open right
hepatectomy. J Gastrointest Surg 15:818–823.
49. Descottes B, Lachachi F, Durand-Fontanier S, Geballa R, Atmani A,
Maisonnette F et al. (2003) Right hepatectomies without vascular clamp-
ing: report of 87 cases. J Hepatobiliary Pancreat Surg 10:90–94.
50. Li C, Mi K, Wen TF, Yan LN, Li B. (2011) Outcome comparison of right
hepatectomy for living liver donation versus for hepatic patients without
cirrhosis. J Gastrointest Surg 15:982–987.
51. Scatton O, Massault PP, Dousset B, Houssin D, Bernard D, Terris B et al.
(2004) Major liver resection without clamping: a prospective reappraisal in
the era of modern surgical tools. J Am Coll Surg 199:702–708.
52. Yamamoto Y, Shimada K, Sakamoto Y, Esaki M, Nara S, Kosuge T.
(2011) Preoperative identification of intraoperative blood loss of more
than 1,500 mL during elective hepatectomy. J Hepatobiliary Pancreat Sci
18:829–838.
53. Azoulay D, Bhangui P, Andreani P, Salloum C, Karam V, Hoti E et al.
(2011) Short- and long-term donor morbidity in right lobe living donor liver
transplantation: 91 consecutive cases in a European Center. Am J Trans-
plant 11:101–110.
54. Burr AT, Csikesz NG, Gonzales E, Tseng JF, Saidi RF, Bozorgzadeh A et al.
(2011) Comparison of right lobe donor hepatectomy with elective right
hepatectomy for other causes in new york. Dig Dis Sci 56:1869–1875.
55. Cho A, Arita S, Koike N, Isaka N, Kusume K, Okazumi S et al. (2007)
Extrahepatic control of the middle hepatic vein with inflow control by
698 HPB
HPB 2012, 14, 688–699 © 2012 International Hepato-Pancreato-Biliary Association
pedicle clamping in major liver surgery. Hepatogastroenterology 54:531–
532.
56. Karaliotas CC, Papaconstantinou T, Karaliotas CC. (2006) Anatomical
variations and anomalies of the biliary tree, veins and arteries. In: Karalio-
tas CC, Broelsch CE, Habib NA, eds. Liver and Biliary Tract Surgery:
Embryological Anatomy to 3D-Imaging and Transplant Innovations. Wien:
Springer-Verlag, pp. 35–48.
57. Otsubo T, Takasaki K, Yamamoto M, Katsuragawa H, Katagiri S, Yoshi-
toshi K et al. (2004) Bleeding during hepatectomy can be reduced by
clamping the inferior vena cava below the liver. Surgery 135:67–73.
58. Kato M, Kubota K, Kita J, Shimoda M, Rokkaku K, Sawada T. (2008)
Effect of infra-hepatic inferior vena cava clamping on bleeding during
hepatic dissection: a prospective, randomized, controlled study. World J
Surg 32:1082–1087.
59. Rahbari NN, Koch M, Zimmermann JB, Elbers H, Bruckner T, Contin P
et al. (2011) Infrahepatic inferior vena cava clamping for reduction of
central venous pressure and blood loss during hepatic resection: a ran-
domized controlled trial. Ann Surg 253:1102–1110.
60. Uchiyama K, Ueno M, Ozawa S, Hayami S, Kawai M, Tani M et al. (2009)
Half clamping of the infrahepatic inferior vena cava reduces bleeding
during a hepatectomy by decreasing the central venous pressure. Lan-
genbecks Arch Surg 394:243–247.
61. Kooby DA, Stockman J, Ben-Porat L, Gonen M, Jarnagin WR, Dematteo
RP et al. (2003) Influence of transfusions on perioperative and long-term
outcome in patients following hepatic resection for colorectal
metastases. Ann Surg 237:860–869. discussion 869–870.
62. Belghiti J, Guevara OA, Noun R, Saldinger PF, Kianmanesh R. (2001)
Liver hanging maneuver: a safe approach to right hepatectomy without
liver mobilization. J Am Coll Surg 193:109–111.
63. Welsh FK, Tilney HS, Tekkis PP, John TG, Rees M. (2007) Safe liver
resection following chemotherapy for colorectal metastases is a matter of
timing. Br J Cancer 96:1037–1042.
HPB 699
HPB 2012, 14, 688–699 © 2012 International Hepato-Pancreato-Biliary Association
